Powered by the world's most comprehensive GLP-1 safety database. Doctor-supervised programmes backed by real data from clinical trials, patient experiences, and regulatory reports.
717
Data points
15
Effects tracked
9
Drugs covered
18
Data sources
See your personalised risk profile for 15 side effects
Try itPredict your weight loss journey based on STEP trial data
Try itAssess your risk of muscle loss and get evidence-based recommendations
Try itUnderstand what happens when you stop — and how to prepare
Try itOur Companies House audit: 98 brand-new shell companies, no credible GLP-1 supplier, and documented harm.
Read moreIndia's patent expiry opens the door for dozens of affordable generic versions.
Read moreRegistered generics make weight management accessible to millions.
Read more
01Complete a confidential health questionnaire. Takes less than 5 minutes.
02A licensed doctor reviews your profile and medical history.
03A personalised plan with evidence-based recommendations tailored to you.
04Weekly check-ins, dose titration, and side effect management.
The grey market sells vials under "research only" disclaimers, with no doctor, no data, and no provenance. We do the opposite.
Every prescription is written by a verified, licensed physician who reviews your medical history, screens for contraindications, and supervises your treatment. No anonymous transactions. No "research only" loopholes.
Get matchedThe world's largest GLP-1 safety and efficacy database — drawn from clinical trials, FDA FAERS, regulatory reports, and patient experiences. Personalised forecasts for weight loss, side effects, and muscle preservation, shared between you and your doctor.
See your forecastLive tracking of GLP-1 supply, demand, and international trade across 51 countries — patent expiries, licensed generic launches, cross-market pricing, and cold-chain integrity. So you know your medicine is legitimate and properly handled.
Explore the marketGeneric semaglutide is now launching in India, Canada, and Brazil. Is it the same as Ozempic? Here's what equivalence actually means — and what to look for.
ReadOzempic costs €300+ per month in some countries and €14 in others. Here's the patent economics behind the price — and why 2026 is changing everything.
ReadConsidering semaglutide for weight management? Here's what to expect in week 1, month 1, and beyond — from dose titration to side effects to lifestyle pairings.
ReadAccess the GLP-1 Safety Database via our public API. Free for citations, subscription for bulk access.
curl magistra.health/api/data?q=overview{
"totalDataPoints": 717,
"effectsTracked": 15,
"drugsCovered": 9,
"sources": ["pubmed", "fda_faers", "reddit", ...]
}Get matched with a verified doctor who can see your personalised risk profile, or join the waitlist to be first in line when we expand to your country.
We'll match you with a verified doctor who can see your personalised risk profile for a better consultation. Free for the first 5 patients.
We're expanding worldwide through 2026-2027.
Personalised weight management, doctor-guided